跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 231 条关于
“Emisar”
全部
231
临床试验
130
药物
18
机构
23
资讯
60
昨天
Florida AG sues Eli Lilly, Novo Nordisk, Sanofi and three PBMs over insulin list prices
去年
Eisai Anticipates EU Decision on BioArctic's Lecanemab in Q2
去年
Eisai and Biogen Pursue Subcutaneous Leqembi Approval for Alzheimer's
去年
Eisai's Remitoro Clears Post-Marketing Surveillance Requirements for T-Cell Lymphoma Treatment in Japan
11个月前
Absci Accelerates ABS-201 Hair Loss Treatment Trial, Announces Expert Seminar for December
去年
Eisai Seeks FDA Approval for Subcutaneous Lecanemab Autoinjector in Alzheimer's
去年
Eisai Completes FDA Submission for Subcutaneous Lecanemab in Early Alzheimer's
去年
Eisai Seeks FDA Approval for Subcutaneous Leqembi in Alzheimer's Maintenance
去年
Eisai Completes FDA Submission for Subcutaneous Lecanemab in Early Alzheimer's
去年
Eisai Completes FDA Submission for Subcutaneous Lecanemab in Alzheimer's Maintenance
第 1 页,共 6 页
上一页
下一页